Replication-incompetent rabies virus vector harboring glycoprotein gene of lymphocytic choriomeningitis virus (LCMV) protects mice from LCMV challenge

Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein

(2017) Benson Y.H. Cheng et al.   VIROLOGY

Vaccine platforms to control Lassa fever

(2016) Igor S. Lukashevich et al.   Expert Review of Vaccines

A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses

(2015) David Safronetz et al.   PLoS Neglected Tropical Diseases

Safety and serological response to a matrix gene-deleted rabies virus-based vaccine vector in dogs

(2014) James P. McGettigan et al.   VACCINE

B Cell Infection and Activation by Rabies Virus-Based Vaccines

(2013) A. G. Lytle et al.   JOURNAL OF VIROLOGY

Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine

(2013) Joseph E. Blaney et al.   PLoS Pathogens

Alternative Serotype Adenovirus Vaccine Vectors Elicit Memory T Cells with Enhanced Anamnestic Capacity Compared to Ad5 Vectors

(2012) Pablo Penaloza-MacMaster et al.   JOURNAL OF VIROLOGY

Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein

(2012) Amy B. Papaneri et al.   VACCINE

A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence

(2012) Amy B. Papaneri et al.   VIROLOGY

Type 1 Interferons and Antiviral CD8 T-Cell Responses

(2012) Raymond M. Welsh et al.   PLoS Pathogens

Argentine hemorrhagic fever vaccines

(2011) Ana Ambrosio et al.   Human vaccines & immunotherapeutics

A highly optimized DNA vaccine confers complete protective immunity against high-dose lethal lymphocytic choriomeningitis virus challenge

(2011) Devon J. Shedlock et al.   VACCINE

Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses

(2011) Rebecca J. Grant-Klein et al.   VIRUS RESEARCH

Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever

(2010) Luis M Branco et al.   Virology Journal

Replication‐Deficient Rabies Virus–Based Vaccines Are Safe and Immunogenic in Mice and Nonhuman Primates

(2009) Jonathan Cenna et al.   JOURNAL OF INFECTIOUS DISEASES

Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene

(2008) Jonathan Cenna et al.   VACCINE

Interferon-β expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity

(2008) Elizabeth J. Faul et al.   VIROLOGY